Jade Biosciences, Inc.
JBIO
$24.71
$0.903.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 461.21M | 311.30M | 336.16M | 198.91M | 220.94M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.05M | 7.22M | 12.66M | 2.46M | 2.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 471.25M | 318.52M | 348.82M | 201.36M | 222.98M |
|
|
|||||
| Total Current Assets | 471.25M | 318.52M | 348.82M | 201.36M | 222.98M |
| Net Property, Plant & Equipment | 793.00K | 847.00K | 896.00K | 916.00K | 924.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 69.00K | 69.00K | 69.00K | 174.00K | 60.00K |
| Total Assets | 472.11M | 319.43M | 349.78M | 202.45M | 223.97M |
|
|
|||||
| Total Accounts Payable | 5.82M | 3.85M | 2.02M | 1.23M | 7.57M |
| Total Accrued Expenses | 15.22M | 15.65M | 14.39M | 16.06M | 10.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 761.00K | 129.00K | 127.00K | 120.00K | 19.00K |
| Total Finance Division Other Current Liabilities | 9.77M | 2.67M | -- | 4.95M | 3.56M |
| Total Other Current Liabilities | 9.77M | 2.67M | -- | 4.95M | 3.56M |
| Total Current Liabilities | 31.57M | 22.29M | 16.54M | 22.36M | 21.62M |
|
|
|||||
| Total Current Liabilities | 31.57M | 22.29M | 16.54M | 22.36M | 21.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 628.00K | 679.00K | 724.00K | 747.00K | 792.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 32.20M | 22.97M | 17.26M | 23.10M | 22.41M |
|
|
|||||
| Common Stock & APIC | 711.10M | 511.56M | 506.78M | 321.77M | 318.86M |
| Retained Earnings | -270.52M | -214.76M | -174.39M | -142.46M | -117.28M |
| Treasury Stock & Other | -660.00K | -342.00K | 129.00K | 29.00K | -24.00K |
| Total Common Equity | 439.91M | 296.46M | 332.52M | 179.35M | 201.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.00K | 2.00K | 2.00K | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.00K | 2.00K | 2.00K | -- | -- |
|
|
|||||
| Total Common Equity | 439.91M | 296.46M | 332.52M | 179.35M | 201.56M |
| Total Preferred Equity | 2.00K | 2.00K | 2.00K | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 439.92M | 296.46M | 332.52M | 179.35M | 201.56M |
|
|
|||||